Mach7 Technologies (ASX:M7T) Cyclically Adjusted PB Ratio: (As of Sep. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:M7T Mach7 Technologies Ltd ASX:M7T
27 GF Score
Price A$0.28
GF Value A$0.87
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Mach7 Technologies Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Mach7 Technologies  (ASX:M7T) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Mach7 Technologies Cyclically Adjusted PB Ratio Related Terms


Mach7 Technologies Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Mach7 Technologies's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mach7 Technologies Cyclically Adjusted PB Ratio Chart

Mach7 Technologies Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.67 3.10 2.89 1.41 0.00

Mach7 Technologies Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.89 0.00 1.41 0.00 0.00

ASX:M7T vs VEEV, BTSG, TEM: Cyclically Adjusted PB Ratio Comparison

For the Health Information Services subindustry, Mach7 Technologies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mach7 Technologies Cyclically Adjusted PB Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mach7 Technologies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Mach7 Technologies's Cyclically Adjusted PB Ratio falls into.


ASX:M7T
27GF Score
Mach7 Technologies Ltd ASX:M7T
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mach7 Technologies Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Mach7 Technologies's Cyclically Adjusted Book per Share for the fiscal year that ended in Jun26 is calculated as:

For example, Mach7 Technologies's adjusted Book Value per Share data for the fiscal year that ended in Jun26 was:

Adj_Book=Book Value per Share/CPI of Jun26 (Change)*Current CPI (Jun26)
=0.147/333.9520*333.9520
=0.147

Current CPI (Jun26) = 333.9520.

Mach7 Technologies Annual Data

Book Value per Share CPI Adj_Book
201706 0.131 244.955 0.179
201806 0.105 251.989 0.139
201906 0.068 256.143 0.089
202006 0.246 257.797 0.319
202106 0.266 271.696 0.327
202206 0.262 296.311 0.295
202306 0.264 305.109 0.289
202406 0.233 314.175 0.248
202506 0.194 322.561 0.201
202606 0.147 333.952 0.147

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Mach7 Technologies (ASX:M7T) Overvalued in 2026?

Based on GuruFocus' analysis, Mach7 Technologies stock appears to be undervalued. The current stock price of A$0.28 is trading 67.8% below its estimated GF Value™ of A$0.87. GuruFocus considers Mach7 Technologies to be Possible Value Trap.

Key valuation signals for ASX:M7T:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: A$0.87 vs. price of A$0.28 (67.8% below fair value)
  • GF Score™: 27/100 with 3 warning signs

No single metric tells the full story. See the ASX:M7T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mach7 Technologies Business Description

Other Exchanges TDMMF:USA
Address 120 Kimball Avenue, Suite 210, South Burlington, VT, USA, 05403
Mach7 Technologies Ltd is a healthcare software company focused on enterprise imaging infrastructure. The company's vendor neutral platform enables health systems to manage, access, and exchange medical imaging data across departments, sites, and vendors. It serves across North America, Asia-Pacific, and the Middle East, with deployments ranging from academic medical centres to multi-site health networks. A substantial part of revenue is derived in the form of Subscription revenue. Geographically, it derives a majority of its revenue from North America.
27GF Score

Get the complete analysis for ASX:M7T

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.28
Price
A$0.87
GF Value